Cliff Asness AQR Capital Management
Cliff Asness is a co-founder of AQR Capital Management, a leading quantitative investment firm spanning equities, alternatives, and factor strategies. He is known for academic-informed research on value, momentum, and other systematic premia, as well as candid market commentary. Asness’s work bridges academic finance and large-scale institutional portfolio management.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$128M |
| 2 |
FedEx
FDX
|
+$120M |
| 3 |
Peloton Interactive
PTON
|
+$97.8M |
| 4 |
Newmont
NEM
|
+$78.9M |
| 5 |
Infosys
INFY
|
+$78.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$309M |
| 2 |
iShares Core S&P 500 ETF
IVV
|
+$291M |
| 3 |
Apple
AAPL
|
+$261M |
| 4 |
Microsoft
MSFT
|
+$240M |
| 5 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$194M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.85% |
| 2 | Healthcare | 15.63% |
| 3 | Consumer Discretionary | 14.74% |
| 4 | Consumer Staples | 10.36% |
| 5 | Industrials | 9.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Micron Technology
MU
$1.09T
| $133M | 0.24% |
1,806,817
-1,189,547
| -40% | -$71.7M |
|
102
Dollar General
DG
$27.2B
| $133M | 0.24% |
634,695
-123,984
| -16% | -$26.5M |
|
|
BNY
103
Bank of New York Mellon
BNY
$108B
| $131M | 0.23% |
3,144,880
-1,153,264
| -27% | -$44.3M |
|
104
Vertex Pharmaceuticals
VRTX
$139B
| $129M | 0.23% |
560,381
-83,887
| -13% | -$19.2M |
|
105
CVS Health
CVS
$119B
| $128M | 0.23% |
1,896,081
-1,064,752
| -36% | -$69.3M |
|
106
Linde
LIN
$225B
| $125M | 0.22% |
477,286
+74,315
| +18% | +$18.2M |
|
107
Pinduoduo
PDD
$126B
| $125M | 0.22% |
700,938
+206,867
| +42% | +$24.7M |
|
108
Trane Technologies
TT
$99.8B
| $123M | 0.22% |
849,688
+503,837
| +146% | +$69.6M |
|
109
Emerson Electric
EMR
$87.7B
| $123M | 0.22% |
1,544,206
+168,512
| +12% | +$12.5M |
|
|
110
Peloton Interactive
PTON
$2.37B
| $122M | 0.22% |
+803,242
| New | +$97.8M |
|
111
Tyson Foods
TSN
$20.6B
| $122M | 0.22% |
1,929,510
-5,222
| -0.3% | -$325K |
|
112
KLA
KLAC
$240B
| $121M | 0.21% |
4,714,520
-807,140
| -15% | -$18.8M |
|
113
VeriSign
VRSN
$25.5B
| $121M | 0.21% |
564,209
-154,499
| -21% | -$31.6M |
|
114
Blackrock
BLK
$179B
| $121M | 0.21% |
170,130
+2,748
| +2% | +$1.82M |
|
115
Progressive
PGR
$127B
| $120M | 0.21% |
1,234,712
+222,398
| +22% | +$21M |
|
116
PayPal
PYPL
$52.7B
| $117M | 0.21% |
507,639
-114,428
| -18% | -$23.7M |
|
117
American Tower
AMT
$81.9B
| $117M | 0.21% |
529,310
-123,790
| -19% | -$28.8M |
|
118
Domino's
DPZ
$11.3B
| $116M | 0.21% |
303,052
-89,228
| -23% | -$35.1M |
|
119
T. Rowe Price
TROW
$23.8B
| $115M | 0.2% |
772,979
-73,233
| -9% | -$10.5M |
|
120
Autodesk
ADSK
$53.6B
| $114M | 0.2% |
375,875
-135,952
| -27% | -$35.8M |
|
121
Philip Morris
PM
$293B
| $112M | 0.2% |
1,370,160
+87,961
| +7% | +$6.85M |
|
122
Tractor Supply
TSCO
$18.2B
| $112M | 0.2% |
3,979,440
-1,162,795
| -23% | -$32.5M |
|
123
Baidu
BIDU
$31.6B
| $111M | 0.2% |
512,959
-60,474
| -11% | -$8.98M |
|
124
Amdocs
DOX
$6.41B
| $109M | 0.19% |
1,564,636
-294,943
| -16% | -$18.5M |
|
125
Intuitive Surgical
ISRG
$134B
| $108M | 0.19% |
397,221
+5,094
| +1% | +$1.26M |
|
Similar funds
Cliff Asness's Q4 2020 Portfolio in Review
As of Q4 2020, Cliff Asness held 2,327 positions worth $56.4B, down 4.7% from $59.2B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
Cliff Asness withdrew a net $9.06B in Q4 2020, closing 151 positions and reducing 1,279 holdings. Its most notable exit was iShares Core S&P 500 ETF, an estimated $291M position sold in full.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 24% a quarter earlier, followed by Healthcare and Consumer Discretionary.
Against the trend, Cliff Asness opened a new position in Peloton Interactive worth $122M.
- Cliff Asness's largest Q4 2020 buy was Peloton Interactive: 803,242 shares worth $122M.
- Cliff Asness added most to Zoom in Q4 2020, an estimated $128M increase.
- Cliff Asness's biggest Q4 2020 reduction was Biogen, cutting an estimated $309M.
- Cliff Asness fully exited iShares Core S&P 500 ETF in Q4 2020, selling an estimated $291M.
- Cliff Asness's ten largest holdings make up 19% of its $56.4B portfolio in Q4 2020.
- Cliff Asness opened 157 new positions and closed 151 in Q4 2020.
- Cliff Asness's portfolio value fell 4.7% quarter-over-quarter to $56.4B.
Based on AQR Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.